04:34 PM EDT, 04/25/2024 (MT Newswires) -- Edwards Lifesciences ( EW ) reported Q1 adjusted earnings Thursday of $0.66 per diluted share, up from $0.62 a year earlier.

Analysts surveyed by Capital IQ expected $0.64.

Net sales in the quarter ended March 31 was $1.60 billion, up from $1.46 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.57 billion.

The company said it expects Q2 adjusted earnings of $0.67 to $0.71 per share on revenue of $1.62 billion to $1.70 billion. Analysts surveyed by Capital IQ project EPS of $0.70 on revenue of $1.65 billion.

Edwards maintained its full-year 2024 adjusted earnings of $2.70 to $2.80 a share. Analysts projected EPS of $2.75.

Price: 89.71, Change: +1.70, Percent Change: +1.93